| Product Code: ETC9974995 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Rat Model Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Rat Model Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Rat Model Market - Industry Life Cycle |
3.4 United States (US) Rat Model Market - Porter's Five Forces |
3.5 United States (US) Rat Model Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Rat Model Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Rat Model Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 United States (US) Rat Model Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 United States (US) Rat Model Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United States (US) Rat Model Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for preclinical research in pharmaceutical and biotechnology industries |
4.2.2 Technological advancements in genetic engineering and CRISPR technology |
4.2.3 Rising focus on personalized medicine and precision healthcare |
4.3 Market Restraints |
4.3.1 Ethical concerns related to the use of animals in research |
4.3.2 Stringent regulatory guidelines and animal welfare regulations |
4.3.3 High cost associated with maintaining and breeding rat models |
5 United States (US) Rat Model Market Trends |
6 United States (US) Rat Model Market, By Types |
6.1 United States (US) Rat Model Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Rat Model Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Rat Model Market Revenues & Volume, By Knockout, 2021- 2031F |
6.1.4 United States (US) Rat Model Market Revenues & Volume, By Outbred, 2021- 2031F |
6.1.5 United States (US) Rat Model Market Revenues & Volume, By Inbred, 2021- 2031F |
6.1.6 United States (US) Rat Model Market Revenues & Volume, By Hybrid, 2021- 2031F |
6.1.7 United States (US) Rat Model Market Revenues & Volume, By Immunodeficient, 2021- 2031F |
6.1.8 United States (US) Rat Model Market Revenues & Volume, By Conditioned, 2021- 2031F |
6.2 United States (US) Rat Model Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Rat Model Market Revenues & Volume, By Nuclear Transferase, 2021- 2031F |
6.2.3 United States (US) Rat Model Market Revenues & Volume, By Microinjection, 2021- 2031F |
6.2.4 United States (US) Rat Model Market Revenues & Volume, By Embryonic Stem Cell, 2021- 2031F |
6.2.5 United States (US) Rat Model Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Rat Model Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Rat Model Market Revenues & Volume, By Cryopreservation, 2021- 2031F |
6.3.3 United States (US) Rat Model Market Revenues & Volume, By Breeding, 2021- 2031F |
6.3.4 United States (US) Rat Model Market Revenues & Volume, By Re-derivation, 2021- 2031F |
6.3.5 United States (US) Rat Model Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.3.6 United States (US) Rat Model Market Revenues & Volume, By Quarantine Depending, 2021- 2031F |
6.3.7 United States (US) Rat Model Market Revenues & Volume, By Other, 2021- 2031F |
6.4 United States (US) Rat Model Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Rat Model Market Revenues & Volume, By Oncology, 2021- 2031F |
6.4.3 United States (US) Rat Model Market Revenues & Volume, By Neurology, 2021- 2031F |
6.4.4 United States (US) Rat Model Market Revenues & Volume, By Immunology, 2021- 2031F |
6.4.5 United States (US) Rat Model Market Revenues & Volume, By Toxicology, 2021- 2031F |
6.4.6 United States (US) Rat Model Market Revenues & Volume, By Other, 2021- 2031F |
6.5 United States (US) Rat Model Market, By End use |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Rat Model Market Revenues & Volume, By CROs, 2021- 2031F |
6.5.3 United States (US) Rat Model Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.5.4 United States (US) Rat Model Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
7 United States (US) Rat Model Market Import-Export Trade Statistics |
7.1 United States (US) Rat Model Market Export to Major Countries |
7.2 United States (US) Rat Model Market Imports from Major Countries |
8 United States (US) Rat Model Market Key Performance Indicators |
8.1 Number of research publications utilizing rat models in the US |
8.2 Adoption rate of genetically modified rat models in preclinical studies |
8.3 Percentage of research funding allocated to in vivo animal studies, including rat models |
9 United States (US) Rat Model Market - Opportunity Assessment |
9.1 United States (US) Rat Model Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Rat Model Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Rat Model Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 United States (US) Rat Model Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 United States (US) Rat Model Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United States (US) Rat Model Market - Competitive Landscape |
10.1 United States (US) Rat Model Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Rat Model Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here